Interventions on metabolic syndrome in postmenopausal women

RUAN Xiangyan,YAN Dan,ZHANG Junli,LU Yongjun,LIU Shunyu,WANG Juan,YIN Dongmei,LIU Yulan,ZHEN Jie
DOI: https://doi.org/10.3969/j.issn.1006-7795.2013.04.008
2013-01-01
Abstract:Objective To explore the efficacy of hormone therapy and lifestyle intervention in metabolic syndrome of postmenopausal women.Methods A total of 121 voluntary participants were recruited,divided into hormone therapy group which contained 64 persons and lifestyle intervention group which contained 57 persons.Hormone therapy group was treated with estradiol valerate combined with dydrogesterone for 6 months plus lifestyle intervention.Lifestyle intervention group was intervened with dietary nutrition guidance and psychological counseling for 6 months.The Kupperman score,anthropometric indicators,serological indicators and the body fat% were measured before and after the interventions.The paired sample test was conducted between the measurements before and after the intervention in hormone therapy group and lifestyle intervention group respectively.The independent samples test was conducted between the measurements after the intervention in hormone therapy group and lifestyle intervention group.Results All the 121 subjects completed the study,including 64 cases of hormone treatment group and 57 cases of lifestyle intervention group.After 6 months of hormone therapy,Kupperman score,body mass index,waist circumference,body fat,serum follicle-stimulating hormone(FSH),triglycerides(TG),low density lipoprotein cholesterol(LDL-C) of hormone therapy group subjects were significantly decreased,and the estradiol(E2),high density lipoprotein cholesterol(HDL-C) levels were significantly increased compared with lifestyle intervention group subjects,the difference between the two groups was statistically significant.But the total cholesterol(TC),fasting plasma glucose(FPG) level,prevalence of metabolic syndrome(MS) were not significantly different compared with the lifestyle intervention group subjects.Conclusion Both hormone therapy and lifestyle intervention could significantly reduce the prevalence of the MS in menopausal women after 6 months intervention.But the hormone therapy plus lifestyle intervention was better than the lifestyle intervention only in improving the menopausal symptoms,decreasing the weight and the body fat increases,prevention of the occurrence and development of metabolic syndrome components in postmenopausal women.
What problem does this paper attempt to address?